Literature DB >> 10232557

Indirect recognition of donor HLA class I peptides in lung transplant recipients with bronchiolitis obliterans syndrome.

K S SivaSai1, M A Smith, N J Poindexter, S R Sundaresan, E P Trulock, J P Lynch, J D Cooper, G A Patterson, T Mohanakumar.   

Abstract

BACKGROUND: The presentation of donor MHC class II-derived peptides by host antigen-presenting cells in the context of self-MHC class II molecules has been suggested as a mechanism for the chronic rejection of kidney and heart allografts. The aim of this study was to determine whether indirect allorecognition of HLA class I-derived peptides occurred in lung transplant (LTx) recipients and whether it correlated with the development of bronchiolitis obliterans syndrome (BOS).
METHODS: Peripheral blood mononuclear cells from LTx recipients were cultured with synthetic peptides corresponding to the hypervariable regions of the mismatched HLA class I antigens of the donor. Proliferation and precursor frequency (PF) of allopeptide reactive T cells were determined by the incorporation of [3H]thymidine into DNA and limiting dilution analysis.
RESULTS: Peripheral blood leukocytes of LTx recipients with BOS mismatched for HLA class I molecules showed a proliferative response three- to fourfold higher than those observed in mismatched recipients without BOS and in normal control individuals (P<0.001). Similarly, the PF of allopeptide-reactive T cell was 3- to 24-fold higher in recipients with BOS compared with recipients without BOS (P<0.05) as well as normal control individuals (P<0.03). The T cell PF to donor-specific allopeptides, as well as irrelevant allopeptides, was not significantly different in LTx recipients without BOS and normal control individuals.
CONCLUSIONS: These data suggest that T cells from LTx recipients are sensitized to mismatched HLA class I antigens. The sensitization was significantly higher in LTx recipients with BOS compared with LTx recipients without BOS. Strategies to block T-cell responses generated by indirect allorecognition after lung transplantation may provide a means for the prevention or treatment of BOS in LTx recipients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10232557     DOI: 10.1097/00007890-199904270-00002

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  20 in total

Review 1.  Monitoring T cell alloreactivity after organ transplantation.

Authors:  J A Bradley; E M Bolton; G Pettigrew
Journal:  Clin Exp Immunol       Date:  2005-11       Impact factor: 4.330

Review 2.  Molecular mechanisms of chronic rejection following transplantation.

Authors:  Elbert Kuo; Takahiro Maruyama; Felix Fernandez; T Mohanakumar
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 3.  Allopeptides and the alloimmune response.

Authors:  Ankit Bharat; T Mohanakumar
Journal:  Cell Immunol       Date:  2007-07       Impact factor: 4.868

Review 4.  Regulatory T cell-mediated transplantation tolerance.

Authors:  Ankit Bharat; Ryan Courtney Fields; T Mohanakumar
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

5.  Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy.

Authors:  R S Lee; K Yamada; S L Houser; K L Womer; M E Maloney; H S Rose; M H Sayegh; J C Madsen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

6.  The direct and indirect allogeneic presentation pathway during acute rejection after human cardiac transplantation.

Authors:  N M van Besouw; J M Zuijderwijk; L M B Vaessen; A H M M Balk; A P W M Maat; P H van der Meide; W Weimar
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

Review 7.  Inflammation in lung transplantation for CF. Immunosuppression and modulation of inflammation.

Authors:  George B Mallory
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

8.  The indirect alloresponse impairs the induction but not maintenance of tolerance to MHC class I-disparate allografts.

Authors:  M J Weiss; D A Guenther; J D Mezrich; H Sahara; C Y Ng; A J Meltzer; J K Sayre; M E Cochrane; A C Pujara; S L Houser; D H Sachs; B R Rosengard; J S Allan; G Benichou; J C Madsen
Journal:  Am J Transplant       Date:  2009-01       Impact factor: 8.086

9.  Immunological link between primary graft dysfunction and chronic lung allograft rejection.

Authors:  Ankit Bharat; Elbert Kuo; Nancy Steward; Aviva Aloush; Ramsey Hachem; Elbert P Trulock; G Alexander Patterson; Bryan F Meyers; T Mohanakumar
Journal:  Ann Thorac Surg       Date:  2008-07       Impact factor: 4.330

10.  Repetitive gastric aspiration leads to augmented indirect allorecognition after lung transplantation in miniature swine.

Authors:  Andrew J Meltzer; Matthew J Weiss; Gregory R Veillette; Hisashi Sahara; Choo Y Ng; Meghan E Cochrane; Stuart L Houser; David H Sachs; Bruce R Rosengard; Joren C Madsen; John C Wain; James S Allan
Journal:  Transplantation       Date:  2008-12-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.